Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents.
Caroline M KopruszinskiJuliana SwioklaYeon Sun LeeEdita NavratilovaLaurie VanderVeenMiao YangYi LiuTakahiro MiyazakiWilliam K SchmidtJonathan ZalevskyFrank PorrecaPublished in: Cellular and molecular neurobiology (2020)
NKTR-181 had a slower onset, but similar efficacy, to morphine in the models studied supporting reduced abuse potential while maintaining analgesic effect in comparison with current opioids.